David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, Inc. (NTLA), sold 4,325 shares at $126.92 ($555K) on 2021-10-14, disclosed to the SEC on 2021-10-15.
Open-market sale of $555k NTLA by EVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.92 | 551 | $70K | 12.6% |
| 2 | $126.92 | 551 | $70K | 12.6% |
| 3 | $127.81 | 849 | $109K | 19.6% |
| 4 | $127.81 | 849 | $109K | 19.6% |
| 5 | $129.01 | 225 | $29K | 5.2% |
| 6 | $129.83 | 525 |
| $68K |
| 12.3% |
| 7 | $129.83 | 525 | $68K | 12.3% |
| 8 | $130.47 | 250 | $33K | 5.9% |
| Total | $128.29 avg | 4,325 | $555K | 100% |
| Filing → |
| NTLA | SELL | 2024-01-05 | $344K | — | Filing → |
| NTLA | SELL | 2023-01-06 | $192K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $236K | — | Filing → |